Treatment for Breast Cancer with Leptomeningeal Metastasis
Study in Patients With Breast Cancer Leptomeningeal Metastasis
Recruiting
Observational Study
Leptomeningeal Metastasis of Breast Cancer
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 Weeks and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 30 (estimated)
- Sponsor
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins · Other
Who this trial is looking for
This trial is looking for patients with breast cancer who may have leptomeningeal metastasis. Participants will help researchers learn about this condition and receive recommendations for treatment.
Are You a Good Fit for This Trial?
You may be able to join if
- I am 18 years old or older
- I have a history of breast cancer
- I have symptoms suggesting breast cancer-related leptomeningeal metastasis
- I have had central nervous system metastasis before
- I have a performance score of 3 or less
You may not be able to join if
- I have a suspected recurrence of a different type of cancer in my brain
- I am not eligible for treatment of leptomeningeal disease
Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.
Think this trial could be right for you?
Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.
Check Your Eligibility
About This Trial
Traditional clinical trials in patients with breast cancer leptomeningeal disease (LMD) are challenging as patients often have a rapidly progressive course and prognosis is poor, making meeting standard eligibility difficult. Furthermore, there is limited information about the biology of LMD. The investigators thus propose a study that is as inclusive as possible, which will allow the investigator…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Male or female, aged 18 or older
* History of breast cancer (any subtype)
* Suspected breast cancer-related leptomeningeal metastasis (i.e., by clinical signs or symptoms (i.e., peri-oral dysesthesia, unexplained new neurological symptoms in the absence of brain metastasis), r…
Contacts